Recent Activity

Loading...

ELVN

Enliven Therapeutics, Inc. · NASDAQ

Performance

-3.6%

1W

+23.27%

1M

+37.22%

3M

+121.11%

6M

+66.47%

YTD

+15.2%

1Y

Profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. Enliven Therapeutics, Inc. is headquartered in Boulder, Colorado.

Investment Analysis Report: ELVN

Overview:

ELVN is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $691,948,976. In this report, we will conduct a comprehensive analysis of ELVN's financial health, earnings and revenue growth, profitability, operating mar...

See more ...

Technical Analysis of ELVN 2024-05-10

Overview:

In analyzing the technical indicators for ELVN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...
See more ...

Recent News & Updates